FDA Approves Blood-Based Prostate Cancer Test
The test receives premarket approval as an aid in biopsy decision-making for men 50 and older with elevated PSA levels.
The test receives premarket approval as an aid in biopsy decision-making for men 50 and older with elevated PSA levels.
The system combines enhanced sensitivity with automation to detect M-proteins at low concentrations, supporting early diagnosis of plasma cell disorders.
The exsig Mag RapidBead Pro kit features a four-step workflow that reduces extraction time to under 20 minutes.
The automated workflow on SPT's firefly platform aims to reduce manual pipetting by up to 80% and improve consistency for large-scale transcriptomic studies.
The Liaison Plex Gastrointestinal Flex Assay detects 24 targets and offers broad parasite coverage with pay-per-target flexibility.